CY1125380T1 - Κατευναστικη φερομονη για γατες - Google Patents

Κατευναστικη φερομονη για γατες

Info

Publication number
CY1125380T1
CY1125380T1 CY20221100501T CY221100501T CY1125380T1 CY 1125380 T1 CY1125380 T1 CY 1125380T1 CY 20221100501 T CY20221100501 T CY 20221100501T CY 221100501 T CY221100501 T CY 221100501T CY 1125380 T1 CY1125380 T1 CY 1125380T1
Authority
CY
Cyprus
Prior art keywords
methyl
cats
calming
pheromone
calming effect
Prior art date
Application number
CY20221100501T
Other languages
Greek (el)
English (en)
Inventor
Patrick Pageat
Original Assignee
Institut De Recherche En Semiochimie Et
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut De Recherche En Semiochimie Et filed Critical Institut De Recherche En Semiochimie Et
Publication of CY1125380T1 publication Critical patent/CY1125380T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61DVETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D99/00Subject matter not provided for in other groups of this subclass
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017Non-human animal skin, e.g. pour-on, spot-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fodder In General (AREA)
  • Steroid Compounds (AREA)
  • Feed For Specific Animals (AREA)
CY20221100501T 2014-03-18 2022-07-25 Κατευναστικη φερομονη για γατες CY1125380T1 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201461954771P 2014-03-18 2014-03-18

Publications (1)

Publication Number Publication Date
CY1125380T1 true CY1125380T1 (el) 2025-05-09

Family

ID=53385673

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20221100501T CY1125380T1 (el) 2014-03-18 2022-07-25 Κατευναστικη φερομονη για γατες

Country Status (22)

Country Link
US (1) US10258594B2 (enExample)
EP (1) EP3119410B1 (enExample)
JP (1) JP6629286B2 (enExample)
CN (2) CN106456590A (enExample)
AU (1) AU2015233067B2 (enExample)
CA (1) CA2943080C (enExample)
CL (1) CL2016002363A1 (enExample)
CY (1) CY1125380T1 (enExample)
DK (1) DK3119410T3 (enExample)
ES (1) ES2923675T3 (enExample)
HR (1) HRP20220957T1 (enExample)
HU (1) HUE059637T2 (enExample)
LT (1) LT3119410T (enExample)
MX (1) MX2016012112A (enExample)
PE (1) PE20161402A1 (enExample)
PL (1) PL3119410T3 (enExample)
PT (1) PT3119410T (enExample)
RU (1) RU2671858C2 (enExample)
SI (1) SI3119410T1 (enExample)
SM (1) SMT202200313T1 (enExample)
WO (1) WO2015140631A1 (enExample)
ZA (1) ZA201606607B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110917241A (zh) * 2019-12-13 2020-03-27 苏州弗艾柏生物科技有限公司 一种猫安抚信息素及其用途
FR3117731A1 (fr) 2020-12-21 2022-06-24 Virbac Dispositifs portables pour animaux de compagnie avec diffusion passive de compositions sémiochimiques
CN112826846A (zh) * 2020-12-31 2021-05-25 武汉研欣生物科技有限公司 猫用安抚信息素及其制备方法与应用
FR3119315B1 (fr) 2021-02-02 2022-12-30 Virbac « gel diffuseur de pheromones »
CN115282128B (zh) * 2022-08-02 2024-03-19 上海弗艾柏生物科技有限公司 猫面部信息素凝胶球及其制备方法
CN116763796B (zh) * 2023-06-20 2024-07-05 咪咪聊(武汉)生物科技有限公司 一种猫用信息素及猫用信息素混合物的制备方法和应用
CN120938981A (zh) * 2025-10-20 2025-11-14 宁波三生生物科技股份有限公司 一种信息素组合物及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426333B1 (en) 1996-09-19 2002-07-30 Merial Spot-on formulations for combating parasites
DK0724832T3 (da) 1995-02-03 2000-04-10 Fideline Egenskaber ved kattes faciale feromoner
US6054481A (en) 1998-01-21 2000-04-25 Fideline Pig appeasing pheromones for enhancing weight gain in a mammal
EP0948963B1 (en) * 1998-01-21 2003-05-07 Fideline Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
FR2795960B1 (fr) * 1999-07-05 2001-10-19 Sanofi Elf Microemulsions stables pour l'administration d'acides gras a l'homme ou a l'animal, et utilisation de ces microemulsions
WO2005039531A1 (en) 2003-10-10 2005-05-06 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
JP2003313104A (ja) * 2002-04-22 2003-11-06 Nippon Kayaku Co Ltd 動物の外部寄生虫駆除用スポットオン剤
AU2003246372B8 (en) * 2002-06-19 2009-03-26 Fideline Avian appeasing pheromones to decrease stress, anxiety and aggressiveness
DE60332635D1 (de) 2002-06-19 2010-07-01 Fideline Le Rieu Neuf Beruhigende vogel-pheromone zur verminderung von stress, angst und aggressivität
FR2931676B1 (fr) * 2008-05-30 2011-01-14 Ceva Sante Animale Nouveaux modes d'administration d'un melange d'acides gras pour le traitement de mammiferes non humains
US8481020B2 (en) * 2009-12-21 2013-07-09 Sergeant's Pet Care Products, Inc. Pheromone compositions and methods of use

Also Published As

Publication number Publication date
CA2943080A1 (en) 2015-09-24
US10258594B2 (en) 2019-04-16
ES2923675T3 (es) 2022-09-29
PL3119410T3 (pl) 2022-09-12
RU2016137349A (ru) 2018-04-18
EP3119410A1 (en) 2017-01-25
US20180169054A1 (en) 2018-06-21
JP6629286B2 (ja) 2020-01-15
HUE059637T2 (hu) 2022-12-28
LT3119410T (lt) 2022-08-25
PE20161402A1 (es) 2016-12-29
AU2015233067B2 (en) 2020-10-22
DK3119410T3 (da) 2022-08-08
RU2016137349A3 (enExample) 2018-04-25
MX2016012112A (es) 2017-04-06
SI3119410T1 (sl) 2022-10-28
AU2015233067A1 (en) 2016-10-20
SMT202200313T1 (it) 2022-09-14
EP3119410B1 (en) 2022-05-04
BR112016021430A2 (pt) 2017-08-15
CL2016002363A1 (es) 2017-07-21
RU2671858C2 (ru) 2018-11-07
CA2943080C (en) 2023-01-17
PT3119410T (pt) 2022-07-22
HRP20220957T1 (hr) 2022-10-28
WO2015140631A1 (en) 2015-09-24
NZ724716A (en) 2022-03-25
CN114732810A (zh) 2022-07-12
JP2017508814A (ja) 2017-03-30
ZA201606607B (en) 2019-12-18
CN106456590A (zh) 2017-02-22

Similar Documents

Publication Publication Date Title
CL2015002865A1 (es) Composiciones de limpieza que contienen una poliéteramina
MX2016002077A (es) Inhibidores de la proteína regulada por glucosa 94 (gpr94) selectivos y usos de los mismos.
BR112017010101A2 (pt) uso de inibidores de ponto de verificação do sistema imune em neoplasias do sistema nervoso central
MX385585B (es) Anticuerpos anti-c10orf54 y usos de los mismos.
PE20151921A1 (es) Virus de la enfermedad de newcastle y usos de los mismos
EP2982238A4 (en) AIR EMISSIONING APPARATUS FOR BREEDING PLANTS
CR20160477A (es) Nanopartículas terapéuticas que comprenden un agente terapéutico, y métodos para su elaboración y uso
MX385987B (es) Intensificadores de aceptabilidad para alimento para mascotas, método de preparación y usos de los mismos.
UY36224A (es) Compuestos tricíclicos de imidazo-pirimidinona
AR093011A1 (es) Alimento para animales que reduce las concentraciones de amoniaco en sus excrementos
PE20170072A1 (es) Composiciones semioquimicas para reducir conflictos sociales con gatos
AR102203A1 (es) Composiciones para el cuidado oral que comprenden zinc, arginina y serina
EA201591397A1 (ru) Хиноксалиноны и дигидрохиноксалиноны как антивирусные средства против респираторно-синцитиального вируса
MX2016012112A (es) Feromona tranquilizadora para gatos.
MX376210B (es) Uso de derivados de isoxazolina para el tratamiento o prevención de infestaciones por artrópodos en aves de corral.
CL2016001587A1 (es) Derivado basado en 1,2-naftoquinona y método de preparación del mismo.
CL2018000451A1 (es) Composiciones de micropartículas que comprenden saflufenacil
UY35947A (es) Compuestos antagonistas selectivos de n-metil-d-aspartato (nmda) subtipo nr2b y composiciones que los contienen
MX2018004796A (es) Conservacion de vitaminas hidrosolubles.
CL2017000074A1 (es) Antagonistas de reproducción de peces
AR101581A1 (es) Composición de colutorio
MX385899B (es) Plantas de lechuga que comprenden resistencia contra el biotipo 1 de nasonovia ribisnigri.
MX2022015141A (es) Composiciones y metodos de uso de un compuesto de control de inapetencia.
TWD169884S (zh) 動物互動裝置
UY34761A (es) Composiciones parasiticidas que comprenden derivados de benzimidazol, métodos y usos de los mismos.